|
|
|
Insider
Information: |
Larosa Joseph J |
Relationship: |
EVP General Counsel an... |
City: |
Kenilworth |
State: |
NJ |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
1 |
|
Direct
Shares |
36,543 |
|
Indirect Shares
|
3,722 |
|
|
Direct
Value |
$35,701,049 |
|
|
Indirect Value
|
$3,636,245 |
|
|
Total
Shares |
40,265 |
|
|
Total
Value |
$39,337,294 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
4
|
Stock
price went up :
|
0
|
2
|
Stock
price went down : |
0
|
2
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
-17.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Regeneron Pharmaceuticals Inc |
REGN |
EVP General Counsel an... |
2024-02-26 |
36,543 |
2024-02-26 |
3,722 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
54 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 3
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
REGN |
Regeneron Pharmaceuticals... |
SVP Gen Counsel & Secretary |
|
2011-09-01 |
4 |
A |
$0.00 |
$0 |
D/D |
10,000 |
10,000 |
0 |
- |
|
REGN |
Regeneron Pharmaceuticals... |
SVP General Counsel and Secret |
|
2015-03-16 |
4 |
AS |
$450.00 |
$8,239,950 |
D/D |
(18,311) |
10,000 |
0 |
- |
|
REGN |
Regeneron Pharmaceuticals... |
SVP General Counsel and Secret |
|
2015-03-16 |
4 |
OE |
$59.20 |
$1,200,635 |
D/D |
20,281 |
11,970 |
0 |
- |
|
REGN |
Regeneron Pharmaceuticals... |
SVP General Counsel and Secret |
|
2015-03-25 |
4 |
OE |
$59.20 |
$183,342 |
D/D |
3,097 |
15,067 |
0 |
- |
|
REGN |
Regeneron Pharmaceuticals... |
SVP General Counsel and Secret |
|
2015-09-01 |
4 |
OE |
$59.20 |
$99,989 |
D/D |
1,689 |
16,756 |
0 |
- |
|
REGN |
Regeneron Pharmaceuticals... |
SVP General Counsel and Secret |
|
2016-09-01 |
4 |
D |
$392.63 |
$1,940,770 |
D/D |
(4,943) |
11,813 |
0 |
- |
|
REGN |
Regeneron Pharmaceuticals... |
EVP General Counsel and Secret |
|
2019-12-11 |
4 |
A |
$0.00 |
$0 |
D/D |
2,625 |
14,438 |
0 |
- |
|
REGN |
Regeneron Pharmaceuticals... |
EVP General Counsel and Secret |
|
2020-04-01 |
4 |
D |
$488.22 |
$4,004,869 |
D/D |
(8,203) |
21,235 |
0 |
- |
|
REGN |
Regeneron Pharmaceuticals... |
EVP General Counsel and Secret |
|
2020-04-01 |
4 |
OE |
$59.20 |
$888,000 |
D/D |
15,000 |
23,924 |
0 |
- |
|
REGN |
Regeneron Pharmaceuticals... |
EVP General Counsel and Secret |
|
2020-04-02 |
4 |
AS |
$484.58 |
$3,330,406 |
D/D |
(6,797) |
14,438 |
0 |
% |
|
REGN |
Regeneron Pharmaceuticals... |
EVP General Counsel and Secret |
|
2020-04-14 |
4 |
OE |
$59.20 |
$296,000 |
D/D |
5,000 |
19,438 |
0 |
- |
|
REGN |
Regeneron Pharmaceuticals... |
EVP General Counsel and Secret |
|
2020-04-14 |
4 |
D |
$521.45 |
$1,427,730 |
D/D |
(2,738) |
16,700 |
0 |
- |
|
REGN |
Regeneron Pharmaceuticals... |
EVP General Counsel and Secret |
|
2020-04-15 |
4 |
AS |
$514.63 |
$1,172,187 |
D/D |
(2,262) |
14,438 |
0 |
% |
|
REGN |
Regeneron Pharmaceuticals... |
EVP General Counsel and Secret |
|
2020-04-16 |
4 |
D |
$529.79 |
$1,447,916 |
D/D |
(2,733) |
16,705 |
0 |
- |
|
REGN |
Regeneron Pharmaceuticals... |
EVP General Counsel and Secret |
|
2020-04-16 |
4 |
OE |
$59.20 |
$296,000 |
D/D |
5,000 |
19,438 |
0 |
- |
|
REGN |
Regeneron Pharmaceuticals... |
EVP General Counsel and Secret |
|
2020-04-17 |
4 |
AS |
$541.94 |
$1,263,586 |
D/D |
(2,267) |
14,438 |
0 |
% |
|
REGN |
Regeneron Pharmaceuticals... |
EVP General Counsel and Secret |
|
2020-04-17 |
4 |
OE |
$59.20 |
$688,022 |
D/D |
11,622 |
22,458 |
0 |
- |
|
REGN |
Regeneron Pharmaceuticals... |
EVP General Counsel and Secret |
|
2020-04-17 |
4 |
D |
$555.82 |
$3,513,894 |
D/D |
(6,322) |
19,738 |
0 |
- |
|
REGN |
Regeneron Pharmaceuticals... |
EVP General Counsel and Secret |
|
2020-04-20 |
4 |
AS |
$567.30 |
$1,013,985 |
D/D |
(1,778) |
14,438 |
0 |
% |
|
REGN |
Regeneron Pharmaceuticals... |
EVP General Counsel and Secret |
|
2020-04-20 |
4 |
AS |
$561.57 |
$1,991,611 |
D/D |
(3,522) |
16,216 |
0 |
% |
|
REGN |
Regeneron Pharmaceuticals... |
EVP General Counsel and Secret |
|
2020-05-14 |
4 |
D |
$573.18 |
$5,692,251 |
D/D |
(9,931) |
22,818 |
0 |
- |
|
REGN |
Regeneron Pharmaceuticals... |
EVP General Counsel and Secret |
|
2020-05-14 |
4 |
OE |
$59.20 |
$1,084,011 |
D/D |
18,311 |
32,749 |
0 |
- |
|
REGN |
Regeneron Pharmaceuticals... |
EVP General Counsel and Secret |
|
2020-05-15 |
4 |
AS |
$572.00 |
$4,793,360 |
D/D |
(8,380) |
14,438 |
0 |
% |
|
REGN |
Regeneron Pharmaceuticals... |
EVP General Counsel and Secret |
|
2020-08-27 |
4 |
OE |
$52.03 |
$520,300 |
D/D |
10,000 |
21,241 |
0 |
- |
|
REGN |
Regeneron Pharmaceuticals... |
EVP General Counsel and Secret |
|
2020-08-27 |
4 |
D |
$614.87 |
$3,276,027 |
D/D |
(5,328) |
19,110 |
0 |
- |
|
54 Records found
|
|
Page 1 of 3 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|